2nd Quarter - Report

WASHINGTON HEALTH STRATEGIES GROUP for ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

clinical trials, clinical research, FDA, R&D tax credit

LobbyistCovered position, as disclosed
SABAH BHATNAGAR New —
JOHN LEWIS —
DOUGLAS PEDDICORD —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.